skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.10e (Release date: 2017-10-30)
SearchBox Top
SearchBox Bottom
NY-ESO-1 Peptide Vaccine (Code C2657)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: NY-ESO-1 Peptide Vaccine

Definition: A cancer vaccine consisting of an immunogenic peptide derived from the cancer-testis antigen (NY-ESO-1), an antigen found in normal testis and various tumors. Vaccination with NY-ESO-1 peptide vaccine may stimulate the host immune system to mount a humoral and cytotoxic T lymphocyte (CTL) response to cells expressing NY-ESO-1 antigen, resulting in tumor cell lysis.

Display Name: NY-ESO-1 Peptide Vaccine

Label: NY-ESO-1 Peptide Vaccine

NCI Thesaurus Code: C2657 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C1134528  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
ESO-1 Peptide Vaccine
NY-ESO-1 Peptide Vaccine

External Source Codes: 
PDQ Closed Trial Search ID 38494
PDQ Open Trial Search ID 38494 (check for NCI PDQ open clinical trial info)
UMLS CUI C1134528

Other Properties:
     Name Value (qualifiers indented underneath)
code C2657
Contributing_Source CTRP
Legacy_Concept_Name NY-ESO-1_Peptide_Vaccine
Semantic_Type Immunologic Factor
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom